Seaport Therapeutics

Seaport Therapeutics is owned by PureTech.

PureTech is one of the...

• FTSE 350.

PureTech is a company listed under the stock ticker PRTC (US).

They are in:

• Biotechnology67%
• Healthcare33%

Acquisition, funding and merger involving PureTech.

• Seaport Therapeutics has just announced a $100 Million fundraising (posted on April 12 2024).

View the org chart displaying its 9 main executives

Most searched biographies at Seaport Therapeutics

• Daphne Zohar, Chief Executive Officer
• Bharatt Chowrira, Board Member
• Denice Torres, Director

Popular executive movements at Seaport Therapeutics

• Denice Torres has joined the company as Director  (posted on May 7 2024).
• Michael Chen has joined the company as Chief Scientific Officer  (posted on May 7 2024).
• Eric Green has joined the company as Chief Operating Officer  (posted on May 7 2024).

Popular executive movements at PureTech

• Bharatt Chowrira, who was President and Chief Business, Finance and Operating Officer, is promoted to Chief Executive Officer  (posted on April 12 2024).
• Robert Lyne will join the company as Chief Portfolio Officer in Jan. 2024  (posted on September 27 2023).

Create your alert
to follow the executive moves at Seaport Therapeutics.

PureTech has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).
• Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Seaport Therapeutics

• Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments – Seaport Therapeutics
• Seaport Therapeutics Launches with $100 Million Oversubscribed Series A Financing Round to Advance Novel Neuropsychiatric Medicines – Seaport Therapeutics
• Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting – Seaport Therapeutics
• News & Papers – Seaport Therapeutics
• News & Papers – Seaport Therapeutics

Social media about Seaport Therapeutics

• Seaport Therapeutics on Wikipedia, Google News & Yahoo Finance
• Seaport Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Eric Green

Call Seaport Therapeutics at +1 617...

View the org chart

Register to receive your alert

Report an error